Novartis's fourth-quarter after-tax profit was $1.98 billion, compared with $936 million in the same period the prior year. Analysts surveyed by FactSet had expected after-tax profit of $1.88 billion. "Novartis 4Q Profit Rises, Buoyed by Sales of New Drugs -- Update," at 0654 GMT and the original story at 0635 GMT, misstated the type of profit in the second and third paragraphs. After-tax profit was $1.98 billion, not pretax profit, and analysts had expected after-tax profit of $1.88 billion, not pretax profit.

(END) Dow Jones Newswires

January 24, 2018 05:45 ET (10:45 GMT)

Copyright (c) 2018 Dow Jones & Company, Inc.
Novartis (NYSE:NVS)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more Novartis Charts.
Novartis (NYSE:NVS)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more Novartis Charts.